Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
PPAR-gamma: therapeutic target for ischemic stroke
Kim D-J, Yu JH, Shin M-S, Shin Y-W, Kim M-S
(NYSE: PFE) announced that based on results from the ongoing pharmacokinetic study (NCT06153758), the company has selected its preferred once-daily modified release formulation for danuglipron, an oral glucagon-like peptide-1 (GLP-1) receptor agonist
With the homologous integration of the linearized plasmids, GSH1 gene of wt W303-1b was deleted or replaced by recombinant DNA fragment of S
doi: 10.7759/cureus.14617 Coogan PF, Bethea TN, Cozier YC, et al
Selected Literature Peer-reviewed publications cited in this overview [1] Coskun T, et al
US$ 27.28
US$ 25.18
US$ 26.69
US$ 29.56
US$ 27.64
US$ 23.11
US$ 26.80
US$ 25.69
US$ 25.49
US$ 26.48
US$ 25.36
US$ 25.41
